 Albaha Barqawi
Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 14 | 2021 | 721 | 1.820 |
Why?
| | Cryotherapy | 1 | 2021 | 15 | 0.890 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 109 | 0.860 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2013 | 33 | 0.510 |
Why?
| | Symptom Assessment | 1 | 2013 | 99 | 0.490 |
Why?
| | Testosterone | 3 | 2013 | 227 | 0.390 |
Why?
| | Mass Screening | 2 | 2005 | 778 | 0.360 |
Why?
| | Prostatic Hyperplasia | 2 | 2005 | 25 | 0.340 |
Why?
| | Erectile Dysfunction | 1 | 2005 | 27 | 0.300 |
Why?
| | Hormone Replacement Therapy | 1 | 2005 | 68 | 0.290 |
Why?
| | Self Medication | 1 | 2004 | 9 | 0.280 |
Why?
| | Prazosin | 1 | 2004 | 35 | 0.270 |
Why?
| | Plant Preparations | 1 | 2004 | 17 | 0.270 |
Why?
| | Prostate-Specific Antigen | 6 | 2007 | 120 | 0.270 |
Why?
| | Phytotherapy | 1 | 2004 | 53 | 0.270 |
Why?
| | Palpation | 1 | 2003 | 8 | 0.260 |
Why?
| | Cryptorchidism | 1 | 2003 | 10 | 0.260 |
Why?
| | Engineering | 5 | 2018 | 47370 | 0.260 |
Why?
| | Social Responsibility | 5 | 2018 | 47385 | 0.260 |
Why?
| | Attitude | 5 | 2018 | 47516 | 0.260 |
Why?
| | Anticarcinogenic Agents | 1 | 2004 | 57 | 0.260 |
Why?
| | Students | 5 | 2018 | 47688 | 0.260 |
Why?
| | Complementary Therapies | 1 | 2004 | 59 | 0.260 |
Why?
| | Vitamins | 1 | 2004 | 109 | 0.250 |
Why?
| | Testis | 1 | 2003 | 100 | 0.250 |
Why?
| | Combined Modality Therapy | 2 | 2021 | 864 | 0.240 |
Why?
| | Adenocarcinoma | 2 | 2007 | 591 | 0.240 |
Why?
| | Neoplasm Staging | 1 | 2004 | 861 | 0.230 |
Why?
| | Male | 22 | 2021 | 90667 | 0.220 |
Why?
| | Dietary Supplements | 1 | 2004 | 306 | 0.220 |
Why?
| | Health Status | 1 | 2005 | 557 | 0.210 |
Why?
| | African Americans | 1 | 2005 | 797 | 0.210 |
Why?
| | Laparoscopy | 1 | 2003 | 290 | 0.210 |
Why?
| | Urination Disorders | 2 | 2013 | 10 | 0.200 |
Why?
| | Humans | 23 | 2021 | 128242 | 0.180 |
Why?
| | Biopsy, Needle | 2 | 2008 | 137 | 0.180 |
Why?
| | Prospective Studies | 2 | 2021 | 4425 | 0.180 |
Why?
| | Ultrasonography, Interventional | 2 | 2008 | 98 | 0.170 |
Why?
| | Survival Rate | 1 | 2021 | 1262 | 0.170 |
Why?
| | Pilot Projects | 1 | 2021 | 1046 | 0.170 |
Why?
| | Imaging, Three-Dimensional | 2 | 2008 | 387 | 0.150 |
Why?
| | Surveys and Questionnaires | 7 | 2018 | 50539 | 0.140 |
Why?
| | Case-Control Studies | 1 | 2021 | 2288 | 0.140 |
Why?
| | Middle Aged | 8 | 2021 | 20385 | 0.140 |
Why?
| | Adult | 8 | 2018 | 70001 | 0.140 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2005 | 90 | 0.140 |
Why?
| | Prognosis | 1 | 2021 | 2491 | 0.140 |
Why?
| | Andropause | 1 | 2013 | 9 | 0.140 |
Why?
| | Nocturia | 1 | 2013 | 7 | 0.140 |
Why?
| | Dexamethasone | 2 | 2006 | 221 | 0.130 |
Why?
| | Urology | 1 | 2013 | 28 | 0.130 |
Why?
| | Socialization | 5 | 2018 | 47368 | 0.130 |
Why?
| | Interviews as Topic | 5 | 2018 | 47819 | 0.130 |
Why?
| | Curriculum | 5 | 2018 | 47915 | 0.130 |
Why?
| | Longitudinal Studies | 5 | 2018 | 49312 | 0.130 |
Why?
| | Adolescent | 6 | 2018 | 60563 | 0.130 |
Why?
| | Follow-Up Studies | 1 | 2021 | 3446 | 0.130 |
Why?
| | Young Adult | 5 | 2018 | 55149 | 0.120 |
Why?
| | Aged | 7 | 2013 | 14374 | 0.110 |
Why?
| | Societies, Medical | 1 | 2013 | 578 | 0.100 |
Why?
| | Female | 5 | 2018 | 92196 | 0.100 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2008 | 186 | 0.100 |
Why?
| | Risk Factors | 3 | 2005 | 6441 | 0.100 |
Why?
| | Androgen Antagonists | 2 | 2006 | 48 | 0.090 |
Why?
| | Models, Anatomic | 1 | 2008 | 69 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 986 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2013 | 824 | 0.080 |
Why?
| | Stroke | 1 | 2013 | 695 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2013 | 1983 | 0.080 |
Why?
| | Carboplatin | 1 | 2006 | 86 | 0.080 |
Why?
| | Orchiectomy | 1 | 2005 | 43 | 0.070 |
Why?
| | United States | 2 | 2013 | 8885 | 0.070 |
Why?
| | Age Distribution | 1 | 2005 | 265 | 0.070 |
Why?
| | Doxazosin | 1 | 2004 | 1 | 0.070 |
Why?
| | Penile Erection | 1 | 2004 | 3 | 0.070 |
Why?
| | Finasteride | 1 | 2004 | 3 | 0.070 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2004 | 28 | 0.070 |
Why?
| | Selenium | 1 | 2004 | 26 | 0.070 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 63 | 0.070 |
Why?
| | Prostate | 1 | 2005 | 122 | 0.070 |
Why?
| | Guidelines as Topic | 1 | 2005 | 206 | 0.070 |
Why?
| | Early Diagnosis | 1 | 2005 | 188 | 0.070 |
Why?
| | Inguinal Canal | 1 | 2003 | 3 | 0.070 |
Why?
| | Seminal Vesicles | 1 | 2003 | 7 | 0.070 |
Why?
| | Peritoneal Cavity | 1 | 2003 | 15 | 0.070 |
Why?
| | Patient Care Planning | 1 | 2004 | 119 | 0.070 |
Why?
| | Vas Deferens | 1 | 2003 | 11 | 0.070 |
Why?
| | Gastroschisis | 1 | 2003 | 10 | 0.070 |
Why?
| | Radiation Injuries | 1 | 2004 | 91 | 0.070 |
Why?
| | Vitamin D | 1 | 2006 | 252 | 0.070 |
Why?
| | Seminoma | 1 | 2003 | 10 | 0.070 |
Why?
| | Anus, Imperforate | 1 | 2003 | 17 | 0.060 |
Why?
| | Cyclooxygenase 2 | 1 | 2004 | 138 | 0.060 |
Why?
| | Hypospadias | 1 | 2003 | 15 | 0.060 |
Why?
| | Cyclophosphamide | 1 | 2003 | 168 | 0.060 |
Why?
| | Carcinoma | 1 | 2004 | 155 | 0.060 |
Why?
| | Drug Utilization | 1 | 2004 | 139 | 0.060 |
Why?
| | Isoenzymes | 1 | 2004 | 275 | 0.060 |
Why?
| | Forecasting | 1 | 2005 | 293 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 2003 | 112 | 0.060 |
Why?
| | Testicular Neoplasms | 1 | 2003 | 71 | 0.060 |
Why?
| | Health Surveys | 1 | 2004 | 344 | 0.060 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2002 | 21 | 0.060 |
Why?
| | Biopsy | 1 | 2005 | 751 | 0.060 |
Why?
| | Comorbidity | 1 | 2005 | 1141 | 0.060 |
Why?
| | Sulfonamides | 1 | 2004 | 331 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2006 | 4819 | 0.050 |
Why?
| | Antioxidants | 1 | 2004 | 399 | 0.050 |
Why?
| | Family | 1 | 2004 | 429 | 0.050 |
Why?
| | Socioeconomic Factors | 1 | 2004 | 802 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2004 | 807 | 0.050 |
Why?
| | Research Design | 1 | 2004 | 645 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2004 | 921 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2004 | 810 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2004 | 873 | 0.040 |
Why?
| | Smoking | 1 | 2005 | 1174 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2013 | 8051 | 0.040 |
Why?
| | Colorado | 1 | 2004 | 3230 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2004 | 1462 | 0.040 |
Why?
| | Mortality | 1 | 2013 | 262 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2013 | 246 | 0.030 |
Why?
| | Infant | 1 | 2003 | 5727 | 0.030 |
Why?
| | Risk | 1 | 2013 | 697 | 0.030 |
Why?
| | Child, Preschool | 1 | 2003 | 6811 | 0.030 |
Why?
| | Child | 2 | 2003 | 12453 | 0.020 |
Why?
| | Subtraction Technique | 1 | 2008 | 22 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 508 | 0.020 |
Why?
| | Rectum | 1 | 2008 | 108 | 0.020 |
Why?
| | Medical History Taking | 1 | 2007 | 99 | 0.020 |
Why?
| | Syndrome | 1 | 2007 | 229 | 0.020 |
Why?
| | Pedigree | 1 | 2007 | 359 | 0.020 |
Why?
| | Veterans | 1 | 2013 | 673 | 0.020 |
Why?
| | Gynecomastia | 1 | 2005 | 3 | 0.020 |
Why?
| | Hot Flashes | 1 | 2005 | 50 | 0.020 |
Why?
| | Cohort Studies | 1 | 2013 | 3676 | 0.020 |
Why?
| | Computer Simulation | 1 | 2008 | 678 | 0.020 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2005 | 48 | 0.020 |
Why?
| | Muscular Diseases | 1 | 2005 | 77 | 0.020 |
Why?
| | Trastuzumab | 1 | 2004 | 67 | 0.020 |
Why?
| | Anemia | 1 | 2005 | 110 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 299 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2004 | 249 | 0.020 |
Why?
| | Animals | 1 | 2004 | 25325 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2005 | 150 | 0.020 |
Why?
| | Osteoporosis | 1 | 2005 | 139 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2006 | 6403 | 0.020 |
Why?
| | Cystostomy | 1 | 2002 | 7 | 0.020 |
Why?
| | Bladder Exstrophy | 1 | 2002 | 13 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2004 | 230 | 0.020 |
Why?
| | Spinal Dysraphism | 1 | 2002 | 25 | 0.010 |
Why?
| | Urethra | 1 | 2002 | 35 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2002 | 149 | 0.010 |
Why?
| | Neural Tube Defects | 1 | 2002 | 48 | 0.010 |
Why?
| | Body Composition | 1 | 2005 | 531 | 0.010 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2004 | 447 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1344 | 0.010 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2004 | 484 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 1803 | 0.010 |
Why?
| | Mental Disorders | 1 | 2005 | 679 | 0.010 |
Why?
| | Quality of Life | 1 | 2002 | 1511 | 0.010 |
Why?
|
|
Barqawi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|